Hassanipour Soheil, Namvar Gholamreza, Fathalipour Mohammad, Salehiniya Hamid
Gastrointestinal & Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, Iran - Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Tabriz University of Medical Sciences, Tabriz, Iran.
Biomedicine (Taipei). 2018 Jun;8(2):9. doi: 10.1051/bmdcn/2018080209. Epub 2018 May 28.
The incidence of kidney cancer from different areas of Iran was reported. Nevertheless, there is no available systematic reviews in this regard. Therefore, the present systematic review carried out to estimate the incidence rate of kidney cancer among Iranian people.
This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) in September 2017. A search was concluded using Medline/ PubMed, Scopus, ScienceDirect, and Google scholar for international papers and four national databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) for Persian papers. The incidence rate of kidney cancer was calculated using random effect model.
An aggregate of 159 papers were retrieved in the primary search of the databases. Further screening and advanced refinement of the retrieved studies produced 15 studies totally. The age-standardized rate (ASR) of kidney cancer was 1.94, 95% CI (1.62-2.55) and 1.36, 95 % CI (1.09-1.62) in males and females, respectively.
In comparison to other parts of the world, the incidence of kidney cancer was lower in Iran. Afterwards, further studies are necessary to outline the exact incidence rate and the trend of kidney cancer in Iran.
伊朗不同地区肾癌的发病率已有报道。然而,在这方面尚无系统综述。因此,本系统综述旨在估计伊朗人群中肾癌的发病率。
本系统综述于2017年9月根据系统综述和Meta分析的首选报告项目(PRISMA)进行。通过检索Medline/PubMed、Scopus、ScienceDirect和谷歌学术搜索国际论文,并检索四个国家数据库(科学信息数据库、MagIran、IranMedex和IranDoc)以获取波斯语论文。使用随机效应模型计算肾癌的发病率。
在数据库的初步检索中总共检索到159篇论文。对检索到的研究进行进一步筛选和完善后,最终得到15项研究。男性和女性肾癌的年龄标准化发病率(ASR)分别为1.94,95%CI(1.62 - 2.55)和1.36,95%CI(1.09 - 1.62)。
与世界其他地区相比,伊朗肾癌的发病率较低。此后,有必要进行进一步研究以明确伊朗肾癌的确切发病率和发病趋势。